ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 8, 2014, Pages

  Alencar, Guilherme Asmar ^a   Lerario, Antonio Marcondes ^a   Nishi, Mirian Yumie ^a   De Paula Mariani, Beatriz Marinho ^a   Almeida, Madson Queiroz ^a   Tremblay, Johanne ^b   Hamet, Pavel ^b   Bourdeau, Isabelle ^b   Zerbini, Maria Claudia Nogueira ^a   Pereira, Maria Adelaide Albergaria ^a   Gomes, Gilberto Carlos ^a   De Souza Rocha, Manoel ^a   Chambo, Jose Luis ^a   Lacroix, André ^b   Mendonca, Berenice Bilharinho ^a   Fragoso, Maria Candida Barisson Vilares ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL HYPERPLASIA; ADULT; AGED; ARMC5 GENE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAZIL; BRAZILIAN; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FAMILIAL DISEASE; FAMILIAL PRIMARY MACRONODULAR ADRENAL HYPERPLASIA; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LINKAGE ANALYSIS; MALE; MIDDLE AGED; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CUSHING SYNDROME; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PEDIGREE; TUMOR SUPPRESSOR PROTEINS;

EID: 84905828393     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4237     Document Type: Article

References (40)

1. Lacroix A. ACTH-independent macronodular adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2009;23:245-259.
2. Stratakis CA, Boikos SA. Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat Clin Pract Endocrinol Metab. 2007;3:748-757.
3. Louiset E, Duparc C, Young J, et al. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med. 2013; 369:2115-2125.
4. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet. 2006;367:1605-1617.
5. Kirschner MA, Powell RD Jr, Lipsett MB. Cushing's syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J Clin Endocrinol Metab. 1964;24:947-955.
6. Findlay JC, Sheeler LR, Engeland WC, Aron DC. Familial adrenocorticotropin- independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 1993;76: 189-191.
7. Oheda T, Noguchi Y, Morio H, Terano T, Hirai A, Tamura T. Study on steroidogenic activity of ACTH-independent macronodular adrenocortical hyperplasia which occurred in brothers in a cancer family. Folia Endocrinol. 1995;71:416-419.
8. Minami S, Sugihara H, Sato J, et al. ACTH independent Cushing's syndrome occurring in siblings. Clin Endocrinol (Oxf). 1996;44: 483-488.
9. Someya T, Koyano H, OsawaY. ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) in two brothers and a sister. Folia Endocrinol. 1996;72:762-766.
10. Imohl M, Koditz R, Stachon A, et al. Catecholamine-dependent hereditary Cushing's syndrome - follow-up after unilateral adrenalectomy [in German]. Med Klin (Munich). 2002;97:747-753.
11. Miyamura N, Taguchi T, Murata Y, et al. Inherited adrenocorticotropin- independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland. Endocrine. 2002;19:319-326.
12. Nies C, Bartsch DK, Ehlenz K, et al. Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members. Exp Clin Endocrinol Diabetes. 2002;110:277-283.
13. Lee S, Hwang R, Lee J, et al. Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clin Endocrinol (Oxf). 2005;63:625-630.
14. Watson TD, Patel SJ, Nardi PM. Case 121: familial adrenocorticotropin- independent macronodular adrenal hyperplasia causing Cushing syndrome. Radiology. 2007;244:923-926.
15. Vezzosi D, Cartier D, Régnier C, et al. Familial adrenocorticotropinindependent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol. 2007; 156:21-31.
16. Gagliardi L, Hotu C, Casey G, et al. Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs- AIMAH): clinical studies of three kindreds. Clin Endocrinol (Oxf). 2009;70:883-891.
17. Bourdeau I, Boisselle A, Rioux D, Neculau M, Hamet P, Lacroix A. Systematic clinical screening of members of a family with hereditary cortisol-secreting B-adrenergic responsive ACTH-independent macronodular adrenal hyperplasia (AIMAH) reveals unsuspected subclinical Cushing's syndrome (CS) and aberrant B-adrenergic regulation of cortisol secretion. Program of the 89th Annual Meeting of The Endocrine Society; June 2-5, 2007; Toronto, Canada; p 148 (Abstract OR54-2).
18. Lacroix A, Bolte E, Tremblay J, et al. Gastric inhibitory polypeptidedependent cortisol hypersecretion-a new cause of Cushing's syndrome. N Engl J Med. 1992;327:974-980.
19. Reznik Y, Allali-Zerah V, Chayvialle JA, et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med. 1992;327:981-986.
20. Lacroix A, Bourdeau I, Lampron A, Mazzuco TL, Tremblay J, Hamet P. Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Clin Endocrinol (Oxf). 2010; 73:1-15.
21. Swords FM, Baig A, Malchoff DM, et al. Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity. Mol Endocrinol. 2002;16:2746-2753.
22. Fragoso MC, Domenice S, Latronico AC, et al. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab. 2003;88:2147-2151.
23. Hsiao HP, Kirschner LS, Bourdeau I, et al. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J Clin Endocrinol Metab. 2009;94:2930-2937.
24. Skogseid B, Larsson C, Lindgren PG, et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1992;75:76-81.
25. Groen EJ, Roos A, Muntinghe FL, et al. Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol. 2008; 15:2439-2450.
26. Matyakhina L, Freedman RJ, Bourdeau I, et al. Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation. J Clin Endocrinol Metab. 2005;90: 3773-3779.
27. Assié G, Libé R, Espiard S, et al. ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome. N Engl J Med. 2013;369:2105-2114.
28. Vincent JM, Morrison ID, Armstrong P, Reznek RH. The size of normal adrenal glands on computed tomography. Clin Radiol. 1994;49:453-455.
29. Sohaib SA, Hanson JA, Newell-Price JD, et al. CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome. AJR Am J Roentgenol. 1999;172:997-1002.
30. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extractingDNAfrom human nucleated cells. Nucleic Acids Res. 1988;16:1215.
31. Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;7:20.
32. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812-3814.
33. Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. Mutation- Taster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575-576.
34. Bromberg Y, Yachdav G, Rost B. SNAP predicts effect of mutations on protein function. Bioinformatics. 2008;24:2397-2398.
35. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357: 1821-1828.
36. Tewari R, Bailes E, Bunting KA, Coates JC. Armadillo-repeat protein functions: questions for little creatures. Trends Cell Biol. 2010; 20:470-481.
37. Berthon A, Martinez A, Bertherat J, Val P. Wnt/β-catenin signalling in adrenal physiology and tumour development. Mol Cell Endocrinol. 2012;351:87-95.
38. Bourdeau I, Antonini SR, Lacroix A, et al. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene. 2004;23:1575-1585.
39. Almeida MQ, Harran M, Bimpaki EI, et al. Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions. J Clin Endocrinol Metab. 2011;96:E728-E738.
40. Swain JM, Grant CS, Schlinkert RT, et al. Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation. Arch Surg. 1998;133:541-545; discussion 545-546.